363 related articles for article (PubMed ID: 6134445)
21. [Treatment of complicated Parkinson disease with a solution of levodopa-carbidopa and ascorbic acid].
Linazasoro G; Gorospe A
Neurologia; 1995; 10(6):220-3. PubMed ID: 7546811
[TBL] [Abstract][Full Text] [Related]
22. Drug-induced parkinsonism and tardive dyskinesia in nonpsychiatric patients.
Grimes JD
Can Med Assoc J; 1982 Mar; 126(5):468. PubMed ID: 6121618
[No Abstract] [Full Text] [Related]
23. Case report: successful use of rectally administered levodopa-carbidopa.
Cooper SD; Ismail HA; Frank C
Can Fam Physician; 2001 Jan; 47():112-3. PubMed ID: 11212422
[No Abstract] [Full Text] [Related]
24. [A year of treatment with carbidopa and levodopa in Parkinsonian patients].
Martínez-Lage JM; Marti-Massó JF; Delgado G; Carreray N; Del Amo F
Rev Clin Esp; 1974 Sep; 134(6):535-42. PubMed ID: 4450036
[No Abstract] [Full Text] [Related]
25. Update on drug treatment of Parkinsonism.
Winkelman AC
Am Fam Physician; 1977 Jul; 16(1):118-20. PubMed ID: 18001
[No Abstract] [Full Text] [Related]
26. Parkinson's disease: recent advances in therapy.
Jankovic J
South Med J; 1988 Aug; 81(8):1021-7. PubMed ID: 3043683
[No Abstract] [Full Text] [Related]
27. Anticholinergics and dyskinesia.
Linazasoro G
Mov Disord; 1994 Nov; 9(6):689. PubMed ID: 7845412
[No Abstract] [Full Text] [Related]
28. Cyproheptadine in levodopa-induced dyskinesia in parkinsonism.
Papavasilliou PS; Cotzias GC; McDowell FH; Rosal VL; Sheehan PJ
Clin Pharmacol Ther; 1978 Feb; 23(2):195-8. PubMed ID: 620480
[TBL] [Abstract][Full Text] [Related]
29. Neuroleptic-induced tardive dyskinesia and parkinsonism: changes during several years of continuing treatment.
Casey DE; Povlsen UJ; Meidahl B; Gerlach J
Psychopharmacol Bull; 1986; 22(1):250-3. PubMed ID: 2873612
[No Abstract] [Full Text] [Related]
30. Effect of increasing regimens of levodopa on chronic MPTP-induced parkinsonism in monkey; mechanographic and electromyographic data.
Doudet D; Gross C; Lebrun-Grandie P; Bioulac B
Electromyogr Clin Neurophysiol; 1986 Dec; 26(8):711-27. PubMed ID: 3493894
[No Abstract] [Full Text] [Related]
31. Response to Sinemet 25/100 in Parkinson's disease.
Ulm G; Gerdes U; Lehmann K
Adv Neurol; 1984; 40():541-7. PubMed ID: 6695634
[No Abstract] [Full Text] [Related]
32. Risk factors for motor response complications in L-dopa-treated parkinsonian patients.
Peppe A; Dambrosia JM; Chase TN
Adv Neurol; 1993; 60():698-702. PubMed ID: 8420213
[No Abstract] [Full Text] [Related]
33. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.
Hinson VK; Goetz CG; Leurgans S; Fan W; Nguyen T; Hsu A
Clin Neuropharmacol; 2009; 32(4):189-92. PubMed ID: 19620848
[TBL] [Abstract][Full Text] [Related]
34. Beneficial effects of combined L-dopa and central anticholinergic in a patient with severe drug-induced parkinsonism and tardive dystonia.
Looper KJ; Chouinard G
Can J Psychiatry; 1998 Aug; 43(6):646-7. PubMed ID: 9729698
[No Abstract] [Full Text] [Related]
35. [Value of low-dose dopa therapy in Parkinson disease].
Petit H; Rousseaux M; Mazingue A; Warot P
LARC Med; 1983; 3(7):514-6. PubMed ID: 6645742
[No Abstract] [Full Text] [Related]
36. [Long term experience with Stalevo in Szeged, Hungary].
Klivényi P; Vécsei L
Ideggyogy Sz; 2009 May; 62(5-6):178-80. PubMed ID: 19579666
[TBL] [Abstract][Full Text] [Related]
37. Response of tardive and L-dopa-induced dyskinesias to antidepressants.
el-Awar M; Freedman M; Seeman P; Goldenberg L; Little J; Solomon P
Can J Neurol Sci; 1987 Nov; 14(4):629-31. PubMed ID: 3690436
[TBL] [Abstract][Full Text] [Related]
38. Sinemet - 25/100.
Med Lett Drugs Ther; 1980 Jun; 22(12):51. PubMed ID: 7374623
[No Abstract] [Full Text] [Related]
39. Sudden onset of confusion with severe exacerbation of parkinsonism during levodopa therapy.
Sage JI; Duvoisin RC
Mov Disord; 1986; 1(4):267-70. PubMed ID: 3504249
[TBL] [Abstract][Full Text] [Related]
40. Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
Zimmerman TR; Sage JI; Lang AE; Mark MH
Mov Disord; 1994 Mar; 9(2):173-7. PubMed ID: 8196678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
